Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 to 75 years old.
- People with a breast phyllodes tumour that has been confirmed by laboratory testing of tissue, and classified as a specific subtype (MN1 or MN2) through specialist molecular testing.
- People whose tumour was fully removed by surgery (with clear margins), either for the first time or after a local return of the tumour on the same side.
- People whose tumour has been confirmed by pathology testing as either borderline or malignant (more serious) type.
- People with no sign that the cancer has spread to other parts of the body.
- People with a good general level of physical functioning, able to carry out normal daily activities with little or no limitation (confirm with trial site what this means for a specific situation).
- People who have signed a consent form before starting any trial treatment.
- People who are expected to begin the study within 8 to 16 weeks after surgery.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously had radiation treatment to the same-side breast or chest area.
- Women who are pregnant, breastfeeding, or who are able to become pregnant but are unwilling to use effective contraception during the trial.
- People with significantly low blood cell counts or elevated liver enzyme levels beyond certain thresholds (confirm specific values with trial site).
- People with serious ongoing health conditions such as severe diarrhoea, serious active infection, uncontrolled illness affecting the whole body, lung disease affecting the tissue between the air sacs, active connective tissue disease, or reduced heart pumping function below a certain level.
- People who have had, or are planned to receive, any systemic cancer treatment — such as chemotherapy, targeted therapy, immunotherapy, or experimental medicines — during the study period.
- People who are already participating in another clinical trial that would conflict with joining this one.
- People who have any other condition that the trial doctor considers makes them unsuitable for the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 020-81332587
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2-year Local Recurrence-Free Survival (LRFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.